Daily weight loss pill could help lose 12% of body weight

Weight loss is a journey that many people step upon; however, struggles arrive in various forms, such as lack of dedication, guidance or resources. People try everything from rigorous exercises to helpful pills just to achieve their desired body shape and weight.

While some work and others do not, the trial of a daily obesity pill has shown that it could help patients lose around 12% of their body weight over 72 weeks.Eli Lilly, the manufacturer of the pills, says the drug, which is not licensed yet, could be available by next year. Orforglipron, the pill, works by suppressing appetite and making you feel full.Preliminary trials of the drug show that those on the highest dose lost an average of 12 kilos over 16 months.

However, about 1 in 10 stopped taking the pills due to side effects such as nausea and vomiting.Not only weight loss, participants also experienced a reduction in cholesterol, blood fats and blood pressure.Dr Kenneth Custer of Eli Lilly stated the company was planning to submit the drug for licensing before the end of the year and preparing for a "global launch to address this urgent public health need."But is the pill better than Mounjaro, Wegovy and Ozempic? It's not. The pill helps with 12% of weight loss compared to 22% weight loss for those on Mounjaro, given by weekly injection. Both drugs are made by the parent company Eli Lilly.However, for those looking for needle-free options, the pill could be a bright light. Additionally, obesity experts hope that it will be far cheaper than the injectables, making it more accessible to patients.